Intellia Therapeutics (NTLA) stock, explained like you're 5

Is Intellia Therapeutics a small, medium or large cap company?

No. Intellia Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Intellia Therapeutics makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves NTLA stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Intellia Therapeutics (NTLA) Stock Looks Overvalued As Launch Preparations Advance (Yahoo Finance)
• More NTLA, Less RKLB: Cathie Wood’s Latest ARK Trades Explained (Stocktwits)
• Is Intellia Therapeutics (NTLA) Cheap Or Pricey On Its New Chief Medical Officer Appointment? (Simply Wall Street)
• Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates (Intellia Therapeutics)
• NTLA Jumps Premarket On Positive Late Stage Trial Data For Gene Editing Therapy Retail Says Buy Now Before It’s Too Late (Stocktwits)

Key terms to know before you follow NTLA

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility